[Federal Register Volume 62, Number 76 (Monday, April 21, 1997)]
[Notices]
[Page 19346]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-10189]
[[Page 19346]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Meetings: National Advisory Allergy and Infectious Diseases Council;
Acquired Immunodeficiency Syndrome Subcommittee; Allergy and Immunology
Subcommittee; Microbiology and Infectious Diseases Subcommittee
Pursuant to Pub. L. 92-463, notice is hereby given of the meeting
of the National Advisory Allergy and Infectious Diseases Council,
National Institute of Allergy and Infectious Diseases, and its
subcommittees on May 19-20, 1997. Meetings of the Council, NAAIDC
Allergy and Immunology Subcommittee, NAAIDC Microbiology and Infectious
Diseases Subcommittee and the NAAIDC Acquired Immunodeficiency Syndrome
Subcommittee will be held at the National Institutes of Health,
Bethesda, Maryland.
The meeting of the full Council will be open to the public on May
19 in Building 31C, Conference Room 6, from approximately 1 p.m. until
3:30 p.m. for opening remarks of the Institute Director, discussion of
procedural matters, Council business, and a report from the Institute
Director which will include a discussion of budgetary matters. The
primary program will include an update on activities of the NIAID
Managed Care Working Group, and NIAID's intramural efforts in clinical
research through tele-medicine.
On May 20 the meetings of the NAAIDC Allergy and Immunology
Subcommittee and NAAIDC Microbiology and Infectious Diseases
Subcommittee will be open to the public from 8:30 a.m. until
adjournment. The subcommittee will meet in Building 31C, conference
rooms 8 and 6 respectively.
The meeting of the NAAIDC Acquired Immunodeficiency Syndrome
Subcommittee will be open to the public from 8:30 a.m. until
adjournment, on May 20. The subcommittee will meet in the Natcher
Building, Conference Room LLD.
In accordance with the provisions set forth in secs. 552b(c)(4) and
552b(c)(6), Title 5, U.S.C. and sec. 10(d) of Pub. L. 92-463, the
meeting of the NAAIDC Acquired Immunodeficiency Syndrome Subcommittee,
NAAIDC Allergy and Immunology Subcommittee and the NAAIDC Microbiology
and Infectious Diseases Subcommittee will be closed to the public for
approximately four hours for review, evaluation, and discussion of
individual grant applications. It is anticipated that this will occur
from 8:30 a.m. until 1 p.m. on May 19, in conference rooms 7, 8 and 6
respectively. The meeting of the full Council will be closed from 3:30
p.m. until recess on May 19 for the review, discussion, and evaluation
of individual grant applications. These applications and the
discussions could reveal confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the applications, disclosure of
which would constitute a clearly unwarranted invasion of personal
privacy.
Ms. Claudia Goad, Committee Management Officer, National Institute
of Allergy and Infectious Diseases, Solar Building, Room 3C26, National
Institutes of Health, Bethesda, Maryland 20892, 301-496-7601, will
provide a summary of the meeting and a roster of committee members upon
request. Individuals who plan to attend and need special assistance,
such as sign language interpretation or other reasonable
accommodations, should contact Ms. Goad in advance of the meeting.
Dr. Lawrence Deyton, Acting Director, Division of Extramural
Activities, NIAID, NIH, Solar Building, Room 3C20, 6003 Executive
Boulevard, Rockville, Maryland 20892, telephone 301-496-7291, will
provide substantive program information.
(Catalog of Federal Domestic Assistance Program Nos. 93.855
Immunology, Allergic and Immunologic Diseases Research, 93.856,
Microbiology and Infectious Disease Research, National Institutes of
Health)
Dated: April 14, 1997.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 97-10189 Filed 4-18-97; 8:45 am]
BILLING CODE 4140-01-M
